ClinicalTrials.gg
Not yet recruitingNCT07811804EASY-AnkleUpdated Sep 10, 2026

Early Ambulation Safely in Unstable Ankle Fractures (EASY-Ankle)

An interventional study of Postoperative Weight-Bearing Rehabilitation Protocol in Trimalleolar Ankle Fracture and Unstable Trimalleolar Ankle Fracture, sponsored by Ottawa Hospital Research Institute. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 13 studies in Ankle Fractures with a site in Canada — 3 open to participants now, 3 under way, none of them phase 3. Ankle Fractures · Canada.

Started
2026
the only one that year
No phase
8 of 13
1 open now
Registered
13th of 13
by date
Lead sponsor
2 of 13
Ottawa Hospital Research Institute

Among the 13 studies in Ankle Fractures with a site in Canada, this one is the only one that started in 2026, is one of 8 with no phase, and was the 13th registered.

Ankle Fractures

202 studies on the registry are indexed under Ankle Fractures; 44 are open to participants now.

Browse Ankle Fractures studies →

Open to participants now

3 of the 13 studies in Ankle Fractures with a site in Canada are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Ankle Fractures with a site in Canada, or all of them as a file.
02

Study summary

This pilot randomized controlled trial will evaluate the safety and feasibility of beginning weight-bearing earlier after surgery for an unstable trimalleolar ankle fracture.

Trimalleolar ankle fractures involve three parts of the ankle and usually require surgery to restore and stabilize the joint. After surgery, patients are commonly instructed not to place weight on the injured ankle for approximately six weeks. However, earlier weight-bearing may improve mobility and recovery without increasing complications. Additional evidence is needed specifically for patients with trimalleolar fractures.

Participants will be randomly assigned in a 1:1 ratio to one of two postoperative rehabilitation groups. The early weight-bearing group will begin placing weight on the injured ankle two weeks after surgery. The delayed weight-bearing group will begin weight-bearing six weeks after surgery, which reflects the current standard approach. Both groups will begin ankle range-of-motion exercises approximately two weeks after surgery.

Participants will be followed for 52 weeks. Ankle function, mobility, quality of life, complications, and routine X-ray findings will be assessed during follow-up. The study will also evaluate participant recruitment, adherence to the assigned rehabilitation protocol, and completeness of study data.

The results will help determine whether a larger randomized controlled trial should be conducted and may contribute to future rehabilitation recommendations for patients recovering from surgically treated trimalleolar ankle fractures.

03

Conditions studied

  • Trimalleolar Ankle Fracture
  • Unstable Trimalleolar Ankle Fracture

Browse trials for

Keywords

  • Early Weight-Bearing
  • Delayed Weight-Bearing
  • Trimalleolar Fracture
  • ORIF
  • Weight-Bearing Rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Operative fixation of an unstable trimalleolar ankle fracture, with or without a syndesmotic injury requiring fixation.
  • Satisfactory anatomical reduction and rigid internal fixation achieved according to established AO principles, including fixation of the posterior malleolus where indicated.
  • Surgery performed within 14 days of the injury.
  • Able and willing to provide .

Exclusion criteria

Exclusion Criteria:

  • Lack of protective sensation, such as peripheral neuropathy.
  • Unable to adhere to trial procedures.
  • Bilateral operatively treated ankle fractures.
  • Treatment of the index fracture with a hindfoot nail.
  • Morbid obesity, defined as greater than 40.
  • Diabetes.
  • Neuroarthropathy.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Early Weight-Bearing

    Participants will remain non-weight-bearing for the first 2 weeks after surgery. Beginning 2 weeks postoperatively, participants will start weight-bearing as tolerated on the affected leg, using walking aids as needed. Participants will also begin standardized active and passive ankle range-of-motion exercises at 2 weeks after surgery.

    Other: Postoperative Weight-Bearing Rehabilitation Protocol

  • Active comparator
    Delayed Weight-Bearing

    Participants will remain non-weight-bearing on the operated leg for 6 weeks after surgery, using walking aids as needed. After 6 weeks, participants may begin weight-bearing as tolerated. Participants will begin the same standardized active and passive ankle range-of-motion exercises at 2 weeks after surgery.

    Other: Postoperative Weight-Bearing Rehabilitation Protocol

Interventions

  • OtherPostoperative Weight-Bearing Rehabilitation Protocol

    Participants will be assigned to one of two postoperative rehabilitation protocols following open reduction and internal fixation of an unstable trimalleolar ankle fracture. The Early Weight-Bearing protocol begins weight-bearing as tolerated at 2 weeks after surgery. The Delayed Weight-Bearing protocol begins weight-bearing as tolerated at 6 weeks after surgery. Both groups begin standardized active and passive ankle range-of-motion exercises at 2 weeks postoperatively.

06

What researchers measure

Primary outcomes

  1. Participant Recruitment Rate

    Feasibility of recruitment will be assessed using the number and proportion of screened patients who meet the eligibility criteria and the proportion of eligible patients who consent to participate. The protocol identifies an eligibility-rate target of at least 60% and a consent-rate target of at least 30%.

    Time frame: Throughout the 12-month recruitment period

  2. Percentage of Participants Adherent to the Assigned Weight-Bearing Protocol

    Participant adherence will be assessed using self-reported compliance with the assigned early or delayed weight-bearing protocol. Measures will include intervention compliance and crossover between treatment groups. The protocol specifies an intervention-compliance target of at least 90% and a crossover-rate target of no more than 5%.

    Time frame: From randomization through 6 weeks after surgery

  3. Completeness of Primary Outcome Data

    Feasibility of data collection will be assessed using the proportion of participants with complete and valid Olerud and Molander Ankle Score data and the proportion lost to follow-up. The protocol specifies a valid primary-outcome-data target of at least 80% and an attrition or loss-to-follow-up target of no more than 15%.

    Time frame: Through 52 weeks after surgery

  4. Olerud and Molander Ankle Score at 3 Months

    Ankle function will be measured using the Olerud and Molander Ankle Score (OMAS). The OMAS ranges from 0 to 100 points, with higher scores indicating better ankle function and fewer symptoms. Scores will be compared between the Early Weight-Bearing and Delayed Weight-Bearing groups. The score assesses ankle symptoms and the ability to perform activities such as walking, running, jumping, and stair use. The protocol specifies a non-inferiority margin of -8 points.

    Time frame: 12 weeks after surgery

Secondary outcomes

  1. Change in Olerud and Molander Ankle Score

    Ankle function, pain, and ability to perform daily activities will be assessed using the Olerud and Molander Ankle Score. Scores range from 0 to 100, with higher scores indicating better ankle function and fewer symptoms.

    Time frame: 6, 12, 26, and 52 weeks after surgery

  2. Foot and Ankle Ability Measure Score

    Foot and ankle function during daily and more demanding activities will be assessed using the Foot and Ankle Ability Measure. Scores are expressed as a percentage from 0% to 100%, with higher scores indicating better function.

    Time frame: 6, 12, 26, and 52 weeks after surgery

  3. EuroQol 5-Dimension 5-Level Score

    Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire. The questionnaire assesses five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is rated on 5 levels; from 1 indicating no problems to 5 indicating extreme problems or inability to perform the activity. Higher levels indicate greater impairment.

    Time frame: 6, 12, 26, and 52 weeks after surgery

  4. Visual Analog Scale Score

    Participants' self-reported health status or pain will be assessed using a visual analog scale (VAS) . Pain will be assessed using a 10 cm VAS ranging from 0 cm (no pain) to 10 cm (pain as bad as it could possibly be).

    Time frame: 6, 12, 26, and 52 weeks after surgery

  5. Incidence of Postoperative Complications

    The number and proportion of participants experiencing postoperative complications will be recorded. Complications include fracture displacement or loss of reduction, non-union, malunion, infection, symptomatic deep vein thrombosis, pulmonary embolism, and unplanned re-operation.

    Time frame: From randomization through 52 weeks after surgery

  6. Incidence of Radiological Loss of Reduction

    Routine postoperative radiographs will be reviewed for loss of reduction. The protocol defines relevant findings as talar subluxation greater than 2 mm, excessive talar tilt greater than 2 degrees, or tibiofibular clear space of at least 5 mm.

    Time frame: 2, 6, 12, 26, and 52 weeks after surgery

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 12 months is below that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2026
First posted
Sep 10, 2026
StartEst.
Sep 8, 2026
Primary completionEst.
Sep 8, 2027
CompletionEst.
Jun 8, 2028
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07811804
Responsible party
Sponsor
First posted
Sep 10, 2026
Start date
Sep 8, 2026 (estimated)
Primary completion
Sep 8, 2027 (estimated)
Completion
Jun 8, 2028 (estimated)
Last update
Sep 10, 2026

Study contacts

Hoda Clinical Research Coordinator
Contact
hghaziasgar@ohri.ca
613-737-8899 ext. 14300
Maryam Clinical Research Coordinator
Contact
marleclerc@ohri.ca
Bradley Meulenkamp, MD, MSc, FRCSC
principal investigator · Ottawa Hospital Research Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion